Test Price
2,800 AED✅ Home Collection Available
RAPSN Gene Fetal Akinesia Deformation Sequence Genetic Test (NGS) in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
Executive Summary – UAE Clinical Gold Standard
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (8 AM – 11 PM daily).
- Clinical Guidance: Complimentary post-test telephonic guidance for result interpretation by a DHA-licensed medical geneticist.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This advanced, physician-ordered genetic test detects pathogenic variants in the RAPSN gene causing fetal akinesia deformation sequence (FADS) and congenital myasthenic syndrome. Using high-depth Next-Generation Sequencing (NGS) with Sanger-confirmed variant calls, it delivers clinically actionable results within 3–4 weeks, fully aligned with DHA molecular diagnostics standards and UAE health data regulations.
Accepted sample types include venous whole blood (EDTA), extracted DNA, or a dried blood spot on an FTA card. A detailed clinical history and pre-test genetic counselling session are mandatory to draw a pedigree chart of affected family members.
| Feature | Our Test (Premium) | Closest Alternative |
|---|---|---|
| Method | Full gene NGS + Sanger Validation | Exome Sequencing (panel-limited) |
| Diagnostic Precision | 99.9% sensitivity for RAPSN variants | May miss deep intronic/regulatory variants |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks (typical) |
Physician Insight & Safety Protocols
"As a medical geneticist, I understand the profound anxiety that accompanies prenatal genetic testing. This test should always be interpreted alongside fetal imaging and a comprehensive genetic counselling session. A negative result does not rule out all genetic causes of akinesia, and a positive result opens the door for precise neonatal planning. We are here to support you at every step."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
Medication Advisory
⚠️ Medication Warning
Do not discontinue or alter any prescribed medication without consulting your physician. Genetic test results are not a substitute for ongoing obstetric care.
Exclusion Criteria & Safety Red Flags
- This test is not intended for direct-to-consumer use; a physician’s referral and informed consent are required under Federal Decree-Law No. 4 of 2016 on Medical Liability.
- For minors, genetic testing requires parental consent and mandatory pre-test genetic counselling in accordance with UAE child protection regulations.
- In cases of acute fetal distress, immediate emergency obstetric care takes precedence—this test is elective and cannot replace urgent clinical interventions.
- Data privacy: All genetic information is protected under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Samples and results are processed exclusively within ISO-certified facilities.
Patient FAQ & Clinical Guidance
1. What is the RAPSN gene and why is it tested for fetal akinesia?
The RAPSN gene encodes a protein essential for neuromuscular junction formation; pathogenic variants cause fetal akinesia deformation sequence and congenital myasthenic syndrome, making NGS analysis critical for prenatal diagnosis.
2. How is the sample collected and is home collection available in the UAE?
A simple blood draw (venous whole blood), extracted DNA, or a dry blood spot on an FTA card is sufficient. Our VIP mobile phlebotomy team provides hospital-grade home collection under a temperature-controlled cold chain, available daily from 8 AM to 11 PM.
3. How accurate is this test and what does a positive result mean?
Our NGS protocol achieves 99.9% diagnostic sensitivity for RAPSN variants. A positive result confirms the presence of a disease-causing mutation, requiring immediate genetic counselling and tailored perinatal management.
UAE Regulatory & Data Privacy Adherence
All genetic testing services at DNA Labs UAE strictly comply with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. Our DHA-licensed facility (License No. 1143) ensures secure handling, analysis, and storage of your genetic data within ISO-certified laboratories.
Clinical & Logistical Metadata
| Test Name | RAPSN Gene Fetal Akinesia Deformation Sequence Genetic Test (NGS) |
| Price (AED) | 2800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Venous whole blood (EDTA), extracted DNA, or dried blood spot (FTA card) |
| Methodology Used | Next-Generation Sequencing (NGS) with Sanger confirmation |
| ICD-10-CM Code | G70.2 (Congenital myasthenic syndrome) |
| LOINC Code | 82919-7 (RAPSN gene targeted mutation analysis) |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE (DNA Labs UAE) |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians